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7RESEARCH ARTICLE Open AccessSurvey of bluetongue virus infection in free-ranging
wild ruminants in Switzerland
Julien Casaubon1, Valérie Chaignat2, Hans-Rudolf Vogt3, Adam O Michel1, Barbara Thür2
and Marie-Pierre Ryser-Degiorgis1*Abstract
Background: In 2006, bluetongue virus serotype 8 (BTV-8) was detected for the first time in central Europe.
Measures to control the infection in livestock were implemented in Switzerland but the question was raised
whether free-ranging wildlife could be a maintenance host for BTV-8. Furthermore Toggenburg orbivirus (TOV),
considered as a potential 25th BTV serotype, was detected in 2007 in domestic goats in Switzerland and wild
ruminants were considered a potential source of infection. To assess prevalences of BTV-8 and TOV infections in
wildlife, we conducted a serological and virological survey in red deer, roe deer, Alpine chamois and Alpine ibex
between 2009 and 2011. Because samples originating from wildlife carcasses are often of poor quality, we also
documented the influence of hemolysis on test results, and evaluated the usefulness of confirmatory tests.
Results: Ten out of 1,898 animals (0.5%, 95% confidence interval 0.3-1.0%) had detectable antibodies against BTV-8
and BTV-8 RNA was found in two chamois and one roe deer (0.3%, 0.1-0.8%). Seroprevalence was highest among
red deer, and the majority of positive wild animals were sampled close to areas where outbreaks had been
reported in livestock. Most samples were hemolytic and the range of the optical density percentage values
obtained in the screening test increased with increasing hemolysis. Confirmatory tests significantly increased
specificity of the testing procedure and proved to be applicable even on poor quality samples. Nearly all samples
confirmed as positive had an optical density percentage value greater than 50% in the ELISA screening.
Conclusions: Prevalence of BTV-8 infection was low, and none of the tested animals were positive for TOV.
Currently, wild ruminants are apparently not a reservoir for these viruses in Switzerland. However, we report for the
first time BTV-8 RNA in Alpine chamois. This animal was found at high altitude and far from a domestic outbreak,
which suggests that the virus could spread into/through the Alps. Regarding testing procedures, hemolysis did not
significantly affect test results but confirmatory tests proved to be necessary to obtain reliable prevalence estimates.
The cut-off value recommended by the manufacturer for the screening test was applicable for wildlife samples.
Keywords: Bluetongue virus, Cross-sectional study, Hemolysis, Switzerland, Toggenburg orbivirus, Wildlife samplesBackground
Bluetongue (BT) is a disease of economic importance [1]
caused by the bluetongue virus (BTV), a RNA-virus that
belongs to the genus Orbivirus of the family Reoviridae.
Twenty-six serotypes have been reported around the
world so far [2]. Although other infection pathways have
been described [3,4], BTV is generally transmitted by bit-
ing midges (Culicoides spp.) [5]. The virus may cause a
hemorrhagic disease with high morbidity rates, especially* Correspondence: marie-pierre.ryser@vetsuisse.unibe.ch
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reproduction in any medium, provided the orin sheep, while cattle mostly act as a reservoir. As an ex-
ception, a high morbidity was observed in this species dur-
ing the recent epidemic due to BTV serotype 8 (BTV-8) in
Europe [6]. Observations during previous BT outbreaks
and experimental infections have shown that indigenous
wild ruminant species may become infected with and
without clinical manifestations and may therefore act as a
virus reservoir [7-12].
Indigenous Swiss cattle and sheep breeds are highly
susceptible to BTV infection and develop clinical signs
[13,14]. The first BTV-8 infection in a domestic animal
in Switzerland was diagnosed at the end of October
2007 [13] and in 2008, like in most European countriesral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vaccination campaign was initiated to limit the expan-
sion of the virus [15]. From 2007 to 2010, 76 local out-
breaks have been reported in Swiss livestock [16]. A
study in wildlife prior to the 2007 epidemic reported no
evidence of BTV infection in Swiss red deer [17]. How-
ever, considering recent data from other European coun-
tries [8,18-20], an update of the situation including more
species from the whole country was necessary to evalu-
ate the potential role of wild ruminants in the BT epi-
demiology in Switzerland and assess whether they may
represent a threat to the success of the control program
in livestock. Furthermore, a new orbivirus named Toggen-
burg orbivirus (TOV) was detected in 2007 in healthy
goats in Switzerland [21]. Since then, it has been shown
that the TOV circulates in small domestic ruminants, es-
pecially in the southern Swiss canton of Ticino (TI), and
the question was raised as to whether wildlife may be a
reservoir for this virus [22,23]. A study addressing risk fac-
tors for TOV infection revealed a possible association with
alpine pastures [24].
In this study, we estimated the prevalence of infections
with BTV and TOV in roe deer (Capreolus c. capreolus),
red deer (Cervus e. elaphus), Alpine chamois (Rupicapra
r. rupicara) and Alpine ibex (Capra i. ibex) over twoFigure 1 Map of Switzerland showing the sampling regions and the d
represent different bioregions, major lakes are in blue. Numbers refer to sam
5) Centre-West, 6) Centre-East, 7) South-West, 8) South-Centre, 9) South-Ea
animals: Orange: roe deer; Dark red: red deer; Green: chamois; Yellow: ibex.
animals. Black areas are communities in which reported domestic BTV outb
Office). The framed small map of Switzerland in the right lower corner of thyears (2009 to 2011). We considered potential risk fac-
tors for infection such as geographical location, altitude,
animal species, age and sex, and we compared our re-
sults with data on domestic ruminants. Given that blood
samples from hunted wildlife are often of poor quality
(e.g. hemolysis), which may affect reactions in serological
tests [25], we investigated the influence of hemolysis on
our testing protocol. Our data show that wild ruminants
are currently not a reservoir for BTV and TOV in
Switzerland. We also confirm that recording serum quality
of samples from hunted wildlife is essential to correctly in-
terpret test results, and that the use of confirmatory tests
is crucial to identify false positive results.
Results
BTV infections
Out of 1,898 serum samples (439 roe deer, 480 red deer,
473 chamois, 506 ibex) screened for BTV antibodies
with the VMRD ELISA, 118 showed an optical density
percentage (ODP, inversely proportional to the optical
density OD) value greater than 30%, which was the cut-
off determined for this study. Ten of the 118 samples
with an ODP > 30% (eight red deer, one roe deer and
one chamois; Figure 1) were eventually confirmed sero-
positive by three additional ELISAs and by Serumistribution of the BTV-8 positive results. Grey shaded areas
pling units: 1) Jura-South, 2) Jura-North, 3) North-West, 4) North-East,
st. Colored dots without halo indicate the location of seropositive
Colored dots with a bright red halo correspond to PCR positive
reaks occurred (data obtained from the Swiss Federal Veterinary
e figure shows the sample distribution (black dots).
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ranging from 1:6 to 1:108 (Table 1 and 2). Only these
confirmed positive samples were used for seroprevalence
calculation. Overall, estimated seroprevalence was 0.5%
(95% confidence interval [CI] 0.3-1%) (Table 1).
With the exception of one roe deer (fawn), all seroposi-
tive animals were adults (no statistically significant differ-
ence between age classes or sexes). There were significantly
more seropositive red deer than roe deer (p = 0.039), cham-
ois (p = 0.038) or ibex (p = 0.003). Among the sampling
units, a significantly higher seroprevalence was recorded in
Jura-South (9.3%, Table 1; p < 0.001 to p = 0.014), and
within this unit, more red deer than roe deer and chamois
(p = 0.004) were seropositive. The elevation above sea level
(a.s.l.) of the seropositive animals did not differ from the
species-specific elevation range for each ruminant species
(Table 3). There was also no difference between the two
sampling periods (2009 and 2010).
None of the 10 seropositive samples was positive by S10
BTV real-time RT-PCR. In contrast, BTV-8 RNA was
detected in 3 out of 1,070 seronegative samples (Ct-values
between 28 and 31). These three samples were from two
adult chamois out of the 118 samples with initial positive
reaction in the VMRD ELISA screening (ODP > 30%) and
from one adult roe deer from the canton of Ticino (sam-
pling unit South Centre, Figure 1) that tested negative in
the VMRD ELISA screening. Virus isolation from these
three samples was not successful. Overall, BTV-8 virus
prevalence was 0.3%, (95% CI 0.1-0.8%) and no animal
was found positive for TOV.Table 1 Prevalences of antibodies against BTV-8 in four speci
Jura Jura North North
South North West East
Roe deer Seroprevalence 0 0 0 0
(95% CI) (0–13.7) (0–5.3) (0–6) (0–4.5
positive / tested 0 /25 0 / 68 0 / 60 0 / 81
Red deer Seroprevalence 29.2 - - 1
(95% CI) (12.6-51.1) (0–5.3
positive / tested 7 / 24 - - 1 /103
Chamois Seroprevalence 0 0 0 0
(95% CI) (0–13.2) (0–5.8) (0–36.9) (0–4.9
positive / tested 0 / 26 0 / 62 0 / 8 0 / 73
Ibex Seroprevalence - - - 0
(95% CI) (0–6.1
positive / tested - - - 0 / 59
Total Seroprevalence 9.3 0 0 0.3
(95% CI) (3.8-18.3) (0–2.8) (0–5.3) (0.01-1.
positive / tested 7 / 75 0 / 130 0 / 68 1 / 316
Samples are classified according to the nine sampling units. Confidence intervals (9The comparison of our results with documented BT
outbreaks in domestic livestock (virus positive animals,
data from the Swiss Federal Veterinary Office; Figure 1)
shows that seropositive wild ruminants were found in a
range from 2.0 to 7.3 km (average of 5.8 km, linear dis-
tance) around communities with domestic outbreaks. In
contrast, two virus positive animals (one chamois and
one roe deer) originated from regions where no domes-
tic BT outbreak has been reported so far [16], at a dis-
tance of 38.0 km and 85.5 km, respectively, to the next
community with a documented outbreak.
Serum quality and testing protocol
The time span between sample collection in the field
and arrival at laboratory was in average 3.2 days with a
range of 0 to 21 days. Of all obtained serum samples,
1,842 were scored (0 to 3) according to their degree of
hemolysis (Figure 2). Only 5% were scored as clean (0)
and 18% as mildly hemolytic (1). Most of the samples
(45%) were classified as moderately hemolytic with de-
creased transparency (2), while 31% were severely
hemolytic and opaque (3). As expected, the proportion
of clean samples was higher in animals sampled alive
(55%) than after death (4%; p < 0.001), while the propor-
tion of moderately to severely hemolytic samples was
similar in hunted animals (77%) and animals found dead
(70%). The distribution of the different hemolysis scores
was generally similar in all four species. However, the
proportion of clean samples was significantly higher in
hunted ibex (7%) than hunted chamois (2%, p = 0.001),es of wild ruminants from Switzerland, 2009-2011
Sampling units
Centre Centre South South South Total
West East West Centre East
0 1.4 0 0 0 0.2
) (0–9.5) (0–7.5) (0–8) (0–20.6) (0–9.7) (0.01-1.3)
0 /37 1 / 72 0 / 44 0 / 16 0 / 36 1 / 439
0 0 0 0 0 1.7
) (0–7.4) (0–8.4) (0–6.5) (0–4.5) (0–2.8) (0.7-3.3)
0 / 48 0 / 42 0 / 55 0 / 80 0 / 128 8 / 480
0 1.5 0 0 0 0.2
) (0–12.8) (0.04-8.3) (0–6.5) (0–9.5) (0–3) (0.01-1.2)
0 / 27 1 / 65 0 / 55 0 / 37 0 / 120 1 / 473
0 0 0 0 0 0
) (0–4.5) (0–7.4) (0–3.9) (0–33.6) (0–1.7) (0–0.7)
0 / 81 0 / 48 0 / 92 0 / 9 0 / 217 0 / 506
0 0.9 0 0 0 0.5
8) (0–1.9) (0.1-3.1) (0–1.5) (0–2.6) (0–0.7) (0.3-1)
0 / 193 2 / 227 0 / 246 0 / 142 0 / 501 10 / 1,898
5% CI) are indicated in parentheses.
Table 2 Relationship between results of the serological tests and sample hemolysis
Score 0 Score 1 Score 2 Score 3 Total
n = 99 n = 338 n = 829 n = 576 n = 1842
ODP ODP ODP ODP ODP ODP ODP ODP ODP ODP
30-49% 50-100% 30-49% 50-100% 30-49% 50-100% 30-49% 50-100% 30-49% 50-100%
Screening ELISA
VMRDa 6 3 18 2 40 13 22 14 86 32
Confirmatory ELISAs
VMRDb 0 3 0 0 0 3 1c 6 1c 12
BDSL 0 2 0 0 0 3 1c 4 1c 9
INGENASA 0 2 0 0 0 3 1c 3 1c 8
Serum Neutralization Test
Titer≥ 1:2 0 2 0 0 0 3 1 4 1 9
Total seropositive 2 0 3 5 10
Confirmed positive / screening
positive (ODP ≥ 30%)
22.2% 0% 5.7% 13.9% 8.5%
Seroprevalence 2.0% 0% 0.4% 0.9% 0.5%
a Cut-off at ODP 30%, b Cut-off at ODP 50%, c Unclear.
Number of positive samples obtained with the screening test (VMRD ELISA) and following confirmatory tests are indicated in relation to the hemolysis serum
scores (0–3) and the optical density percentage (ODP) of the screening test. One sample with ODP > 30% yielded an unclear result in the confirmatory ELISAs but
to a positive result in the SNT (cut-off ≥ 1:2).
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date of sampling and the date of arrival at the Centre for
Fish and Wildlife Health (FIWI) was longer for samples of
hunted ibex (3.3 days, range of 1 to 19 days) than of hunted
chamois (3.1 days, range of 0 to 21 days) (p = 0.012). Never-
theless, when the animal species was not considered,
hemolysis generally increased with the time betweenTable 3 Sample size and population data for the four wild ru
Species Geographical data*
Bioregion Min Mean altitude
m.a.s.l. (SD)
Roe deer Jura 393 783 (231)
Plateau 355 553 (126)
Alps 374 1,195 (445)
South 272 731 (337)
Red deer Jura 474 764 (375)
Alps 402 1,254 (399)
South 238 940 (465)
Alpine chamois Jura 434 940 (279)
Plateau 532 650 (160)
Alps 431 1,840 (547)
South 312 1,164 (540)
Alpine ibex Alps 673 2,294 (392)
* Data from the animals sampled in this study.
** Data obtained from the Swiss Federal Office of the Environment [55].
Population size is based on counts and estimates from wildlife managers and biolo
Mean altitudes differed significantly between species (p < 0.05): Ibex were found hig
red deer (all bioregions).sampling and sample processing (2.8 days for score 0, and
3.6 for score 3).
In the screening VMRD ELISA, severely hemolytic sam-
ples (score 3) showed a significantly lower ODP mean
value than samples with lower scores (p < 0.001; Figure 3),
and the overall range of ODP values was wider with in-
creasing hemolysis. Positive results were confirmed bothminant species sampled in the study
Population data 2010**
Max Estimated population
size
Hunting bag
1,228 112,975 39,664
938
2,504
1,417
1,557 28,483 9,016
2,604
2,094
1,581 91,390 13,339
1,007
3,103
2,087
3,154 15,553 1,074
gists.
her than all other species (Alps), and chamois were higher than roe deer and
Figure 2 Typical appearance of thawed serum samples and
attributed hemolysis scores. 0 = clean and transparent; 1 = mildly
hemolytic, transparent; 2 = moderately hemolytic, decreased
transparency; 3 = severely hemolytic and opaque.
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lence was 2.0% for clean samples (score 0) and 0.6% for
markedly hemolytic samples (score 2 and 3), without stat-
istical difference between the two groups, and with even a
lower prevalence for only slightly hemolytic samples
(0%, score 1; Table 2).
Ten out of 118 samples (8.5%) were eventually con-
firmed seropositive by repeating the VMRD ELISA in a
different laboratory by other technicians and by two
other ELISAs and SNT (Table 2). The percentage of
confirmed positive among screening-positive samples
was higher for score 0 (22.2%) than for scores 2 and 3
(5.7% and 13.9%, respectively) but these differences were
not significant. Overall, final seroprevalence (10/1,898,
0.5%) was significantly lower than the initial one (screen-
ing test: 118/1,898, 6.2%; p < 0.001) even if considering
only samples with ODP > 50% (9/1,898 confirmed versus
32/1,898 positive in the screening test, p < 0.001).
Except for one out of the 10 samples confirmed as posi-
tive after running confirmatory tests, all of these had an
initial ODP > 50% (Table 2, Figure 3). Thus, the estimated
seroprevalence using 50% as cut-off (9/1,898, 0.47%)Figure 3 Box plots of the VMRD ELISA results in relation to
serum quality. Red dots represent the BTV-8 seropositive animals as
confirmed by SNT. Dashed line indicates the 50% cut-off value
defining a positive sample as recommended by the manufacturer.would have not significantly differed from the one
obtained with the cut-off at 30% (10/1,898, 0.52%; p = 1).
Discussion
Following the recent BT epidemic in central Europe,
data on BTV circulation in Swiss free-ranging wild rumi-
nants were urgently needed for the future planning and
successful achievement of the implemented BT control
program in livestock. This study provides an overview of
the situation in the four indigenous wild ruminant spe-
cies in Switzerland, and it additionally addresses import-
ant questions regarding testing protocols for samples
collected from wildlife carcasses.
The low estimated seroprevalence for BTV in all in-
vestigated species suggests that sporadic infection can
occur but that BTV-8 is not circulating within wild pop-
ulations in Switzerland at a large scale. Also, the preva-
lence in red deer of 1.7% in the present study was not
significantly higher (p = 0.058) than reported before the
European epidemic (0%, CI 0–1.54%) [17].
The fact that the prevalences in our study were lower
than the ones previously documented in other European
countries [8,19,20] can be due to two different factors.
First, albeit 76 BT outbreaks have been recorded in
Swiss livestock between 2007 and 2010 [16], this number
is very low compared to the situation observed in other
countries [26], e.g. 26,500 herds with clinical cases in
2008 in France [27]. The virus has apparently not spread
as widely in Switzerland as in other European regions.
Second, our sampling rounds took place after two years
of mandatory vaccination of Swiss domestic ruminant
species [15], a measure that limited the incidence of
BTV-8 infections in domestic and possibly also in wild
species [8,28].
In our study, red deer were more often infected by
BTV-8 than other wild ruminant species, similarly to ob-
servations in Belgium [8], Spain [19], and France [20].
This supports the hypothesis that, although they live in
the same habitat, red deer are more susceptible to infec-
tion than roe deer. It is interesting to note that red deer
are abundant in the southern part of the Swiss Jura
while only few individuals are present in its northern
part [29], where most of the domestic Swiss BT out-
breaks occurred [16]. In contrast, roe deer and chamois
are abundant in the northern Jura [29] but none of the
individuals from this region (133 samples) were positive.
This further suggests that ruminants other than red deer
have a lower susceptibility to infection or that BTV-
infected midges do not feed on them as often. In conclu-
sion, it indicates that outbreaks in livestock were likely
not related to wildlife infections.
It has been formerly of concern that BTV may expand
from southern Europe through the Alps but data from
2004–2005 did not indicate virus presence in regions
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our study we found a chamois positive by real-time RT-
PCR, originating from an Alpine valley (Engadin, canton
of Graubünden), which was sampled above 2,000 m a.s.l.
To our knowledge, this is the first report of BTV-8 RNA
in an Alpine caprid. It has been shown that there are
no vector-free areas in Switzerland, and different species
of Culicoides midges have been detected up to 2,100 m
a.s.l. in the Swiss Alps, indicating that virus may be able to
circulate within the Alps [30]. Although anecdotal, our
result supports this hypothesis.
During previous BT epidemics in Europe, the situation
in wildlife seemed to be closely related to the spread of
BTV among domestic livestock [18]. However, seroposi-
tive wild animals have also been documented in regions
without domestic outbreaks [31], a situation that was
particularly obvious for BTV-8 in southern Spain [19].
In contrast to Spain, where wild ruminants may act as
reservoir for BTV [19,31], our data indicate that wildlife
plays currently no such role in Switzerland. First,
seroprevalences in wildlife are very low; second, all
seropositive wild ruminants were sampled in a peri-
meter of < 5.8 km around a domestic outbreak, while
95% of the new domestic outbreaks during the 2006
BT epidemic occurred within a perimeter of 31 km
from the first one [32]. In our study, two infected wild
ruminants were found in areas distant of more than
30 km from the nearest Swiss domestic case (38.0 km
and 85.5 km, respectively) but virus dispersion over
large distances through wind transport of infected
midges is well known [31]. Alternatively, infected do-
mestic animals in these areas may have remained un-
detected or unreported. The detection of clinically ill
animals in rigorously vaccinated herds and the health
monitoring of livestock kept on alpine pastures are
challenging. Furthermore, one of the two positive wild ru-
minants originated from a location close to the Italian
border and may have been related to domestic cases in
northern Italy. Indeed, BTV-8 cases have been recorded in
Piemonte [33] but to our knowledge, detailed information
on the epidemiological situation in this region is not pub-
licly available. Nevertheless, these two virus positive ani-
mals demonstrate that wild ruminants, as it has already
been addressed [34], should imperatively be included in
future BT surveillance programs for early detection of
disease.
Concerning TOV, our study suggests that wildlife is
not a reservoir for this virus either. Despite the high
apparent TOV seroprevalence in goats (49% at individ-
ual level and of 60% at herd level) in the canton of Ti-
cino and the fact that TOV had circulated in the
population of domestic small ruminants in 2008 and
2009 [22], TOV-positive wild animals were not found
in this region.Serological surveys in free-ranging wild species are
linked with a range of difficulties including laborious
sampling (few samples obtained despite intensive cap-
ture efforts, dependence of hunters and gamekeepers for
access to hunted animals), limited representativity of
obtained sample sets (sampling bias due e.g. to hunting
or capture season and hunting plans), poor sample qual-
ity (hemolysis, contamination of different origin), and
lack of validation of serological tests for wild species.
Poor serum quality can hamper analysis and complicate
result interpretation. However, the impact of sample
quality depends largely on the type of serological test.
Hemolysis has been shown to be a major problem when
using serum neutralization tests (SNT) due to serum
cytotoxicity and to the presence of cloudy suspensions
interfering with the reading of the test [19]. Hemolytic
and strongly contaminated samples are also considered
inadequate for the complement fixation test and serum
agglutination test [35], and decreased sensitivity due to
hemolysis was observed when testing samples of wild-
cats with an immunofluorescence assay [36] and fallow
deer sera with an ELISA [37]. Similarly, a recent study
on Suid Herpesvirus 1 showed that hemolysis and re-
peated freeze-thawing cycles of wild boar sera can influ-
ence ELISA test reactions, leading to a higher number of
doubtful results [24]. In contrast, hemolysis and repeated
freeze-thawing cycles have been reported to have only a
relatively small effect on the obtained optical density
(OD) values of an ELISA applied on domestic pig sera
[38]. However, it is difficult to evaluate which factor is
most important when the impact of hemolysis on test
results is addressed in association with suboptimal stor-
age conditions. For example, long sample storage time at
room temperature has been shown to increase the num-
ber of false negative results [39]. Here, we evaluated the
influence of hemolysis on serological tests in four differ-
ent wild ruminant species. As expected, the majority of
the samples collected from hunted and perished animals
was moderately to severely hemolytic, in contrast to
samples from living animals. We documented that the
range of ODP values was wider and the mean ODP
value lower in case of severe hemolysis, indicating a
higher risk of obtaining false negative results when ap-
plying recommended cut-offs on hemolytic samples.
However, only one hemolytic sample with ODP < 50%
was confirmed positive in other tests, suggesting that
false negative results due to hemolysis is negligible.
Nevertheless, this result should be considered with cau-
tion given the very low number of positive samples in
our study.
Our testing protocol, which combined an initial highly
sensitive screening procedure with more specific con-
firmatory tests, was intended to detect weak positive
antibody reactions as expected after a recent BTV
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allowed us to identify such samples to test them individu-
ally for virus RNA, while seronegative samples were tested
in pools. Independently of the degree of hemolysis, a high
number of samples identified as positive in the screening
test turned out to be negative in the confirmation tests,
which was due in large part to the low cut-off value set in
the screening test. However, even when considering only
samples with an ODP > 50%, the use of confirmatory tests
proved to be essential to minimize the number of false
positive reactions. Based on our experience, we recom-
mend re-testing samples showing a weak positive or ques-
tionable result. If samples are truly only weakly positive,
they will produce the same reaction in the second run; in
contrast, false positive results are mostly not repeatable.
Despite the known limitations of the SNT when applied
on hemolytic samples, we obtained acceptable results in
all cases. This success is probably due to our use of a
lower TCID50 than the one recommended by the OIE,
namely 20–40 TCID50 instead of 100 TCID50. This proto-
col modification has been shown to be more sensitive
without a loss of specificity for the detection of antibodies
against BTV [40]. The serial serology testing procedure
privileged specificity because only samples that scored
positive in at least two out of three confirmatory ELISAs
as well as in the SNT were considered positive. However,
sample selection for investigation by real-time RT-PCR
was based on the results of the screening test only, in-
creasing the chances of detecting viremic animals.
Three samples determined as seronegative were positive
for BTV RNA by real-time RT-PCR. In the case of BTV in-
fection, viremia can be detected up to a couple of months
after infection in domestic and wild species, usually in
seropositive animals [12]. However, the virus may be occa-
sionally found in seronegative individuals, as it has been
reported in red deer from Belgium [8]. This could be either
related to a recent infection (before seroconversion) or due
to a failure in antibody detection (false seronegative).
Pooling seronegative samples for PCR analyses may
have decreased sensitivity of the test. However, we were
looking for epidemiologically relevant virus amounts as-
sociated with a clearly positive reaction; even in the case
of a low virus load, we would have expected the animals
to be seropositive. Therefore, the pooling procedure
allowed saving resources without affecting result quality.
While the storage of blood samples at −20°C is not con-
sidered problematic for the real-time RT-PCR, virus iso-
lation could have been negatively influenced by this
temperature. This may explain the failure of isolation
from the three positive RT-PCR samples.
Conclusions
Our aim was to assess the role of wild ruminants in the
epidemiology of BTV infections in domestic livestock inSwitzerland. Our data suggest that BTV infections in
wild ruminants are only sporadic and that this virus does
not circulate among wild populations. We therefore con-
clude that wildlife is currently an incidental spill-over
and not a maintenance host in Switzerland and does not
represent a threat for the BTV control program in live-
stock. Similarly, we found no evidence of TOV infec-
tions in wild hosts. However, the presence of BTV-8 in
areas distant from reported cases in domestic species
suggests that the BTV-8 situation may evolve in the near
future and that wild ruminants could be used as senti-
nels for BT surveillance. Additionally, our data suggest
that hemolytic samples can be used for serosurveys, but
they underline the importance of running confirmatory
tests to refine results obtained by sensitive screening
procedures.
Methods
Study design and sampling strategy
This study was based on a cross-sectional convenient
sampling strategy aiming also at estimating the apparent
prevalence of infections with the bovine viral diarrhea
virus in Swiss wild ruminants [41]. The whole territory
of Switzerland (41,285 km2) was divided in nine sam-
pling units (Figure 1) based on definitions for the BT
monitoring program in Swiss livestock [42], political
units (cantons), environmental factors influencing the
probability of vector occurrence [43], the occurrence of
wild ruminants, and documented BTV and TOV infec-
tions in livestock. Additionally, the altitude range (AR) of
the main four Swiss bioregions was determined to assess
the potential role of altitude as a risk factor for infection:
Jura: 273–1,679 m a.s.l., Plateau: 244–1,290 m a.s.l., Alps:
263–4,634 m a.s.l., South: 193–2,887 m a.s.l. We also cal-
culated the mean altitude of sampling locations for each
species in each bioregion (Table 3).
Sampling was carried out from August 2009 to April
2011, and the required sample size for “detection of dis-
ease” was calculated with the WinEpiscope 2.0 software
package [44], assuming an expected maximal prevalence
of 1% for virus positive animals, with a confidence inter-
val of 95% and an accepted error of 5%. We aimed at a
total of 300 animals per species and year [41].
Sample collection and animals
Blood samples were collected between 2009 and 2011.
This study did not involve purposeful killing of animals
and was exempt from ethical approval according to
Swiss legislation. Samples originated mainly from dead
wildlife legally hunted during the hunting season (922.0
hunting law; for details on sampling organization, see
[41]). Few animals submitted for necropsy as carcasses
to the Centre for Fish and Wildlife Health (FIWI) or
captured in the fields in the frame of other wildlife
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Capture and sampling of living animals (n = 24) were
carried out with the authorizations of the competent au-
thorities, as requested by Swiss legislation (455 animal
protection law, including legislation on animal experi-
mentation; authorization numbers GR 24/06 and VD
1863). Sampling conditions (hunt, found dead, capture),
sampling date, and biological data were recorded for
each animal. In dead animals, blood was collected from
the heart or from body cavities. In living animals, blood
was drawn from the jugular vein under anesthesia. Blood
samples were transferred into tubes with and without
anticoagulant (EDTA), sent to the laboratory, and serum
samples were centrifuged immediately upon reception.
Aliquots of sera and whole blood were stored at −20°C
until analysis.
Blood samples of 1,898 wild ruminants were collected
from all over the country. Slightly more males (n = 1,012)
than females (n = 878) were sampled, and information on
sex was missing for eight animals. The majority of the
samples came from adult individuals (≥ 2 years; n = 1,365),
followed by yearlings (1 to < 2 years; n = 302) and fawns/
kids (< 1 year; n = 221). Information on age was missing
for 10 animals. Depending on available blood quantity,
samples were tested for BTV antibodies and/or for the
presence of viral RNA.
Laboratory analyses
Prior to serological screening tests, thawed serum sam-
ples were scored according to their color and opacity.
(0 = clean and transparent; 1 = mildly hemolytic, trans-
parent; 2 = moderately hemolytic, decreased transpar-
ency; 3 = severely hemolytic and opaque; Figure 2).
For the detection of BTV-specific antibodies, serum
samples were first screened with a commercial competi-
tive ELISA kit (Bluetongue Virus Antibody Test Kit,
cELISA, VMRD, Inc., Pullman, U.S.A.; referred to as
VMRD ELISA) that detects antibodies against all BTV-
serotypes [45] including BTV-26 and TOV [22]. The test
was performed according to the manufacturer’s instruc-
tions but we used the ODP instead of the OD to classify
results. A sample is positive if it produces an OD lower
than 50% of the mean of the negative controls; when
using ODP values, a sample is positive when the ODP
value is equal to or higher than 50% of the mean of the
negative controls. However, for the screening test, we
decided to set the cut-off at an ODP value of 30% be-
cause we wanted to detect recently infected animals
displaying a weak antibody reaction below the normal
cut-off and additionally test them for BTV by real-time
RT-PCR. Reactions to anti-TOV antibodies are often
weak and early time-point seroconversions are rarely
detected with normal testing procedures [23,46]. Fur-
thermore, this test has not yet been validated for wildspecies and it is not known whether the antibody reaction
with samples from wildlife is as strong as with samples
from domestic animals. For seroprevalence estimation,
positive samples were subsequently re-analyzed with the
VMRD ELISA following manufacturer’s recommendations
and with two other kits: another competitive ELISA (Blue
Tongue Competitive ELISA Kit, B.D.S.L, Irvin, Scotland,
UK; referred to as BDSL ELISA) and an ELISA based on
the double recognition principle (INGEZIM BTV DR,
INGESANA, Madrid, Spain; referred to as INGENASA
ELISA). Samples that yielded positive results in at least
two different confirmatory ELISAs were subsequently ana-
lyzed with a SNT specific for BTV-8 antibodies. Briefly,
two-fold serial dilutions of serum samples starting at 1:2
were made in 96-well plates. Each dilution was titrated
against the Northern European BTV-8 strain (kindly pro-
vided by the Friedrich-Loeffler-Institute, Riems, Germany)
by adding an equal volume of virus solution containing
20–40 TCID50/50 μL. The 96-well plates were incubated
for 1 h at 37°C and 5% CO2. Then, 100 μL of a 1.5 × 10
5/
mLVero cell suspension were added per well, and after in-
cubation for 4 to 7 days at 37°C and 5% CO2, the wells
were scored for cytopathic effect. The neutralization titer
was determined as the dilution of serum yielding a 50%
neutralization end point. Any neutralization was consid-
ered to be positive.
Positive samples in the first VMRD ELISA (cut-off set
at 30%) were tested individually by real-time RT-PCR.
Additionally a subset of seronegative samples was tested
in pools of five samples each, including all available
samples collected in 2009 from all sampling units as well
as those collected in 2010 from the sampling unit South
(canton of Ticino), because numerous TOV-infected
goats were found in this region [24]. Total RNA was
purified following a combination of a manual protocol
using TRIzol® (Life Technologies Ltd, Paisley, UK) and a
semi-automatic commercial extraction kit (NucleoSpin®
96 RNA, Marcherey-Nagel, Düren, Germany) as pre-
viously described [47]. Briefly: 250 μL EDTA-blood
was mixed with 750 μL TRIzol® and 10 μL glycogen
(Fluka-Chemie AG, Buchs, Switzerland) and an internal
positive control to detect PCR inhibition. After adding
200 μL chloroform (Merck, Darmstadt, Germany) and
centrifugation step according to the published protocol
[47], the upper phase was mixed 1:1 with ethanol 100%.
In a second step, this mixture was used as matrix for an
automated RNA extraction using NucleoSpin® 96 RNA
kit. The RNA was then tested by real-time RT-PCR
employing the S10-specific protocol able to detect all
BTV-serotypes, inclusively TOV [48]. In S10-specific
real-time RT-PCR positive samples, a serotype-8 spe-
cific commercial real-time RT-PCR was performed
(TaqVet® Blue Tongue Virus Triplex – All Genotypes
and BTV8, LSI, Lissieu, France) and if negative a TOV
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where a pool yielded a positive result, samples within that
pool were additionally tested as single reactions. For virus
isolation, washed blood or cell culture supernatant were in-
oculated intravenously into 10–12 days old SPF embryo-
nated chicken eggs as described by the OIE Guidelines [49].
Data management and statistical analysis
Data handling, validation, cleaning and coding were
done in MS Excel© spread sheets followed by transfer to
the NCSS 2007 software (Hintze, J. (2007). NCSS 2007.
NCSS, LLC. Kaysville, Utah, USA. www.ncss.com) for
statistical analyses. Prevalences were calculated assuming
test sensitivity and specificity of 100%. The two-tailed
Fischer’s exact test (FET) was used to determine differ-
ences in prevalence of infection among age classes,
sexes, geographical regions and sampling periods. The
Mann–Whitney U test was used to test differences be-
tween means of altitude. Both tests were applied to study
differences between means of optical density percentage
(ODP) of the VMRD ELISA among sera with different
scores and among species. Level of significance was set
at p < 0.05. Non-interpretable serological and PCR re-
sults were not included in the statistical analyses.
Maps were designed using the gvSIG software, version
1.11.0 final (© gvSIG Association). Elevation of animal
location at sampling time as well as altitude range of the
four Swiss bioregions (based on the definition of the
Federal Office of the Environment [50]) were calculated
with the ArcView GIS software 3.0a and adapted on the
basis of appropriate literature [51].
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